<DOC>
	<DOCNO>NCT01149863</DOCNO>
	<brief_summary>Typically , collection blood cell autologous stem cell transplant do drug granulocyte colony-stimulating factor ( G-CSF ) plerixafor give activate bone marrow stem cell produce certain type blood cell , call CD34+ cell . Currently , plerixafor give evening , 11 hour apheresis ( removal blood ) begin follow morning . The purpose study test whether plerixafor instead give 17 hour apheresis . This timing would convenient since plerixafor would give normal clinic hour , patient would within clinic environment side effect develop . The study look activation CD34+ cell patient receive plerixafor 17 hour apheresis . We follow number patient achieve target number CD34+ cell , total number CD34+ cell collect . These compare number previous study give plerixafor 11 hour apheresis . We also assess safety give plerixafor 17 hour apheresis .</brief_summary>
	<brief_title>Alteration Timing Plerixafor Administration</brief_title>
	<detailed_description />
	<mesh_term>JM 3100</mesh_term>
	<criteria>1 . Age 1870 year 2 . MM patient first second complete partial remission 3 . ECOG performance status 0 1 4 . Up 3 prior treatment regimens 5 . Meet eligibility requirement autologous transplant 6 . Adequate marrow function define WBC &gt; 3,000 ; ANC &gt; 1,500/mm3 ; Platelets &gt; 75,000/mm3 7 . Adequate renal function define creatinine clearance &gt; 30 mL/min CockcroftGault 8 . Adequate liver function define AST/ALT/Bilirubin &lt; 2 time upper limit normal 9 . Able provide inform consent 10 . Women pregnant agree use contraception 1 . High risk comorbidities acute treatment complication ( e.g. , symptomatic coronary artery disease ) 2 . Brain metastasis carcinomatous meningitis 3 . Previous treatment high dose chemotherapy autologous transplant . 4 . Previous attempt collect BHPCs follow mobilization growth factor alone , growth factor chemotherapy , plerixafor growth factor . 5 . Acute infection unexplained fever &gt; 38Â°C 6 . Weight &gt; 175 % ideal body weight defined Devine equation . 7 . Experimental therapy within 4 week 8 . Cytokine administration previous 14 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Autologous Transplantation</keyword>
</DOC>